These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 950259)

  • 21. Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.
    Wade M; Baker FJ; Roscigno R; DellaMaestra W; Arneson CP; Hunt TL; Lai AA
    J Clin Pharmacol; 2004 May; 44(5):503-9. PubMed ID: 15102871
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propoxyphene use and risk for hip fractures in older adults.
    Kamal-Bahl SJ; Stuart BC; Beers MH
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):219-26. PubMed ID: 17062322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pharmacokinetic model of the adjustment of phenprocoumon (Falithrom) dosage.
    Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):838-50. PubMed ID: 6083961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetics of fluvoxamine: applications to dosage regimen design.
    DeVane CL; Gill HS
    J Clin Psychiatry; 1997; 58 Suppl 5():7-14. PubMed ID: 9184622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clopidogrel loading dose regimens: kinetic profile of pharmacodynamic response in healthy subjects.
    Savcic M; Hauert J; Bachmann F; Wyld PJ; Geudelin B; Cariou R
    Semin Thromb Hemost; 1999; 25 Suppl 2():15-9. PubMed ID: 10440417
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiopulmonary, behavioral, and pharmacokinetic effects of propoxyphene in horses.
    Muir WW; Sams RA; Huffman R
    Am J Vet Res; 1980 Apr; 41(4):575-80. PubMed ID: 7406276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Simultaneous estimation of propoxyphene-do and propoxyphene-d2 levels by quantitative mass fragmentography. Potential utility in multidose investigations.
    Sullivan HR; Wood PG; McMahon RE
    Biomed Mass Spectrom; 1976 Oct; 3(5):212-6. PubMed ID: 974235
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentration of propoxyphene in human plasma following repeated oral doses.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):493-7. PubMed ID: 5571352
    [No Abstract]   [Full Text] [Related]  

  • 29. Enhancement of propoxyphene-induced analgesia by doxepin.
    Tofanetti O; Albiero L; Galatulas I; Genovese E
    Psychopharmacology (Berl); 1977 Jan; 51(2):213-5. PubMed ID: 402676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propoxyphene and norpropoxyphene kinetics after single and repeated doses of propoxyphene.
    Inturrisi CE; Colburn WA; Verebey K; Dayton HE; Woody GE; O'Brien CP
    Clin Pharmacol Ther; 1982 Feb; 31(2):157-67. PubMed ID: 7056023
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propoxyphene and norpropoxyphene plasma concentrations in the anephric patient.
    Gibson TP; Giacomini KM; Briggs WA; Whitman W; Levy G
    Clin Pharmacol Ther; 1980 May; 27(5):665-70. PubMed ID: 7371364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propoxyphene and norpropoxyphene: influence of diet and fluid on plasma levels.
    Welling PG; Lyons LL; Tse FL; Craig WA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):559-65. PubMed ID: 1277712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.
    Wolen RL; Gruber CM; Kiplinger GF; Scholz NE
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):480-92. PubMed ID: 4936997
    [No Abstract]   [Full Text] [Related]  

  • 34. Propoxyphene bioavailability: an evaluation of ten products.
    Slywka GW; Melikian AP; Whyatt PL; Meyer MC
    J Clin Pharmacol; 1975; 15(8-9):598-604. PubMed ID: 1150913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dextropropoxyphene kinetics after single and repeated oral doses in man.
    Brøsen K; Gram LF; Schou J; Larsen NE; Thayssen P
    Eur J Clin Pharmacol; 1985; 29(1):79-84. PubMed ID: 4054208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of food and liquid on the pharmacokinetics of propoxyphene.
    Musa MN; Lyons LL
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):669-74. PubMed ID: 819224
    [No Abstract]   [Full Text] [Related]  

  • 37. Determination of propoxyphene and norpropoxyphene by chemical ionization mass fragmentography.
    Wolen RL; Ziege EA; Gruber CM
    Clin Pharmacol Ther; 1975 Jan; 17(1):15-20. PubMed ID: 1122667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-propoxyphene kinetics in man: significance of a deep third compartment.
    Gram LF; Schmidt K; Christensen FN; Schou J
    Eur J Clin Pharmacol; 1984; 26(6):749-52. PubMed ID: 6489415
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propoxyphene and norpropoxyphene plasma concentrations after oral propoxyphene in cirrhotic patients with and without surgically constructed portacaval shunt.
    Giacomini KM; Giacomini JC; Gibson TP; Levy G
    Clin Pharmacol Ther; 1980 Sep; 28(3):417-24. PubMed ID: 7408401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin.
    Nash JF; Scholz NE; Maxwell SB
    Toxicol Appl Pharmacol; 1971 Jul; 19(3):537-45. PubMed ID: 5571353
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.